Tannic Acid and Copper-Modified ZIF-8 Metal Organic Framework as a Cefotaxime Delivery System for Antimicrobial Activity

MakaleYayıncıda açık erişimScopus SJRQ2
  • SDG 3 · Sağlık ve Kaliteli Yaşam

Özet

Objectives: Antibiotic resistance has become a global public health threat. Cefotaxime (CTX), a third-generation cephalosporin, is approved for use in infants, children, and adults with various microbial infections, particularly those affecting the central nervous system. This study aimed to synthesize and characterize zeolitic imidazolate framework (ZIF)-8-based drug delivery systems (DDSs) to enhance antimicrobial activity and control CTX release. Materials and Methods: ZIF-8 was synthesized via the coordination network of Zn ions and 2-methylimidazole and subsequently modified with tannic acid (TA) and copper ions (Cu2+). ZIF-8 MOF and its derivatives were characterized by Fourier Transform Infrared, zeta potential, in vitro dissolution rate, and in vitro antimicrobial activity. Conclusion: ZIF-8 MOF DDS may serve as an alternative for delivering drugs to infected areas due to their controlled release under low pH conditions. Results: The drug loading capacity and encapsulation efficiency were found to be 39.50 ± 1.19% and 98.75 ± 2.96%, respectively, for ZIF-8@ TA@CTX, and 40.75 ± 1.22% and 97.75 ± 2.93%, respectively, for ZIF-8@TA@Cu@CTX. Following 48 hours, the drug released from ZIF-8@TA@ Cu@CTX was detected at 62.83 ± 1.89% at pH 5.0 and 83.19 ± 2.50% at pH 7.4 after 48 h, with dissolution profiles best fitting the Korsmeyer– Peppas model. The synthesized DDSs demonstrated a higher antibacterial activity against gram-positive bacteria than against gram-negative bacteria.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/kostu/10699Resmi atıflarda kullanılan kalıcı adres
İndeks kayıtları
Kaydın indeks veri tabanlarındaki sayfası (aktarımda alınan kayıt numarasıyla). Erişim, indeksin kendi koşullarına bağlıdır.
Atıflar
Scopus
0
WoS
1
OpenAlex
0
TR Dizin
0
Her kaynağın kendi saydığı toplam atıf; aktarım ve zenginleştirme sırasında alındı.
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTok, Yağmur Pirinççi
dc.contributor.authorÖzsoy, Münteha
dc.contributor.authorÇelik, Damla Damar
dc.date.accessioned2026-10-27T23:47:44.849554154Z
dc.date.available2026-10-27T23:47:44.849554154Z
dc.date.issued2026
dc.description.abstractObjectives: Antibiotic resistance has become a global public health threat. Cefotaxime (CTX), a third-generation cephalosporin, is approved for use in infants, children, and adults with various microbial infections, particularly those affecting the central nervous system. This study aimed to synthesize and characterize zeolitic imidazolate framework (ZIF)-8-based drug delivery systems (DDSs) to enhance antimicrobial activity and control CTX release. Materials and Methods: ZIF-8 was synthesized via the coordination network of Zn ions and 2-methylimidazole and subsequently modified with tannic acid (TA) and copper ions (Cu2+). ZIF-8 MOF and its derivatives were characterized by Fourier Transform Infrared, zeta potential, in vitro dissolution rate, and in vitro antimicrobial activity. Conclusion: ZIF-8 MOF DDS may serve as an alternative for delivering drugs to infected areas due to their controlled release under low pH conditions. Results: The drug loading capacity and encapsulation efficiency were found to be 39.50 ± 1.19% and 98.75 ± 2.96%, respectively, for ZIF-8@ TA@CTX, and 40.75 ± 1.22% and 97.75 ± 2.93%, respectively, for ZIF-8@TA@Cu@CTX. Following 48 hours, the drug released from ZIF-8@TA@ Cu@CTX was detected at 62.83 ± 1.89% at pH 5.0 and 83.19 ± 2.50% at pH 7.4 after 48 h, with dissolution profiles best fitting the Korsmeyer– Peppas model. The synthesized DDSs demonstrated a higher antibacterial activity against gram-positive bacteria than against gram-negative bacteria.
dc.identifier.doi10.4274/tjps.galenos.2026.80025
dc.identifier.eissn2148-6247
dc.identifier.endpage40
dc.identifier.issn1304-530X
dc.identifier.issue1
dc.identifier.pmcidPMC13360780
dc.identifier.pmid41960755
dc.identifier.scopus2-s2.0-105046044829
dc.identifier.startpage31
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/kostu/10699
dc.identifier.volume23
dc.identifier.wosWOS:001823396600001
dc.language.isoen
dc.publisherTurkish Pharmacists Association
dc.relation.ispartofTurkish Journal of Pharmaceutical Sciences
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntibiotic resistance
dc.subjectcefotaxime
dc.subjectmetal organic framework
dc.subjectzeolitic imidazolate frameworks
dc.subject.classificationPharmacology & Pharmacy
dc.subject.othercefotaxime
dc.subject.othercephalosporin
dc.subject.othercopper
dc.subject.othermetal organic framework
dc.subject.othermethyl group
dc.subject.othertannin
dc.subject.otherunclassified drug
dc.subject.otherZeolitic imidazolate framework 8
dc.subject.otherzinc ion
dc.subject.otherantibacterial activity
dc.subject.otherantibiotic resistance
dc.subject.otherantimicrobial activity
dc.subject.otherArticle
dc.subject.othercentral nervous system
dc.subject.othercentrifugation
dc.subject.othercontrolled study
dc.subject.otherdissolution
dc.subject.otherdrug delivery system
dc.subject.otherdrug release
dc.subject.otherencapsulation
dc.subject.otherFourier transform infrared spectroscopy
dc.subject.otherGram negative bacterium
dc.subject.otherin vitro study
dc.subject.otherin vivo study
dc.subject.otherminimum bactericidal concentration
dc.subject.otherminimum inhibitory concentration
dc.subject.othernonhuman
dc.subject.otherparticle size
dc.subject.otherpH
dc.subject.otherPseudomonas aeruginosa
dc.subject.otherStaphylococcus aureus
dc.subject.otherultraviolet visible spectroscopy
dc.subject.otherzeta potential
dc.titleTannic Acid and Copper-Modified ZIF-8 Metal Organic Framework as a Cefotaxime Delivery System for Antimicrobial Activity
dc.typeArticle
rdl.citation.openalex0
rdl.citation.scopus0
rdl.citation.trdizin0
rdl.citation.wos1
rdl.departmentİstanbul Health and Technology University Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Türkiye
rdl.departmentKocaeli Health and Technology University Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Kocaeli, Türkiye
rdl.departmentMarmara University Faculty of Pharmacy, Department of Pharmaceutical Microbiology, İstanbul, Türkiye
rdl.oa.statusgold
rdl.oa.statusgreen
rdl.scopus.quartileQ2
rdl.sdgSDG03
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexTRDIZIN
rdl.source.indexPUBMED
rdl.wos.indexEmerging Sources Citation Index (ESCI)